Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.

@article{Fisher2012VisualOI,
  title={Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.},
  author={Michael J Fisher and Michael J Loguidice and David H Gutmann and Robert H. Listernick and Rosalie E. Ferner and Nicole N J Ullrich and Roger J. Packer and Uri Tabori and Robert O. Hoffman and Simone L Ardern-Holmes and Trent R. Hummel and D Hargrave and Eric Bouffet and Joel Charrow and Larissa T. Bilaniuk and Laura Joan Balcer and Grant T. Liu},
  journal={Neuro-oncology},
  year={2012},
  volume={14 6},
  pages={790-7}
}
Optic pathway gliomas (OPGs) occur in 15%-20% of children with neurofibromatosis type 1 (NF1); up to half become symptomatic. There is little information regarding ophthalmologic outcomes after chemotherapy. A retrospective multicenter study was undertaken to evaluate visual outcomes following chemotherapy for NF1-associated OPG, to identify risks for visual loss, and to ascertain indications for treatment. Subjects included children undergoing initial treatment for OPGs with chemotherapy… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS
55 Citations
31 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 55 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Prognostic factors for progression of childhood optic pathway glioma: a systematic review

  • E Opocher, LC Kremer, L Da Dalt
  • Eur J Cancer
  • 2006
1 Excerpt

Similar Papers

Loading similar papers…